Merck & Co New: (NYSE: MRK)

$47.33

0.62 (1.33%)

Volume 22,541,865

May 23 04:00 PM ET

Zacks Rank: 3-Hold

 
 
#3
 
 

Cash flow Statements

Get Cash flow Statements for:

Annual Cash Flow Statement

Fiscal Year End for MERCK & CO INC falls in the month of December.

All data in Millions except Per Share data.

Cash Flow From Operations, Investments & Financial Activities

12/31/12 12/31/11 12/31/10 12/31/09 12/31/08
Cash Flow From Operations, Investments & Financial
Activities
         
Net Income (Loss) 6,299.00 6,392.00 982.00 13,024.20 7,808.40
Depreciation/Amortization & Depletion 6,978.00 7,427.00 7,381.00 2,576.00 1,631.20
Net Change from Assets/Liabilities -4,136.00 -766.00 930.00 -2,706.90 -2,894.00
Net Cash from Discontinued Operations 0.00 0.00 0.00 0.00 0.00
Other Operating Activities 881.00 -670.00 1,529.00 -9,501.30 26.09
Net Cash From Operating Activities 10,022.00 12,383.00 10,822.00 3,392.00 6,571.70
Property & Equipment -1,954.00 -1,723.00 -1,678.00 -1,460.60 -1,298.30
Acquisition/ Disposition of Subsidiaries 0.00 -50.00 -256.00 -12,972.60 0.00
Investments -5,058.00 -1,176.00 -2,636.00 7,871.10 -901.50
Other Investing Activities 207.00 59.00 1,073.00 9,718.10 365.40
Net Cash from Investing Activities -6,805.00 -2,890.00 -3,497.00 3,156.00 -1,834.40

Uses of Funds

12/31/12 12/31/11 12/31/10 12/31/09 12/31/08
Cash Flow From Operations, Investments & Financial
Activities
         
Net Income (Loss) 6,299.00 6,392.00 982.00 13,024.20 7,808.40
Depreciation/Amortization & Depletion 6,978.00 7,427.00 7,381.00 2,576.00 1,631.20
Net Change from Assets/Liabilities -4,136.00 -766.00 930.00 -2,706.90 -2,894.00
Net Cash from Discontinued Operations 0.00 0.00 0.00 0.00 0.00
Other Operating Activities 881.00 -670.00 1,529.00 -9,501.30 26.09
Net Cash From Operating Activities 10,022.00 12,383.00 10,822.00 3,392.00 6,571.70
Property & Equipment -1,954.00 -1,723.00 -1,678.00 -1,460.60 -1,298.30
Acquisition/ Disposition of Subsidiaries 0.00 -50.00 -256.00 -12,972.60 0.00
Investments -5,058.00 -1,176.00 -2,636.00 7,871.10 -901.50
Other Investing Activities 207.00 59.00 1,073.00 9,718.10 365.40
Net Cash from Investing Activities -6,805.00 -2,890.00 -3,497.00 3,156.00 -1,834.40
Issuance (Repurchase) of Capital Stock -1,281.00 -1,600.00 -1,230.00 186.40 -2,622.70
Issuance (Repayment) of Debt 2,540.00 -1,547.00 658.00 4,202.70 -1,392.00
Increase (Decrease) Short-Term Debt 624.00 1,076.00 90.00 -2,422.00 1,859.90
Payment of Dividends & Other Distributions -5,236.00 -4,811.00 -4,853.00 -3,479.10 -3,278.50
Other Financing Activities 86.00 -22.00 -106.00 -126.30 -89.20
Net Cash from Financing Activities -3,267.00 -6,904.00 -5,441.00 -1,638.30 -5,522.50
Effect of Exchange Rate Changes -30.00 42.00 -295.00 33.40 -182.60
Net Change In Cash & Equivalents -80.00 2,631.00 1,589.00 4,943.10 -967.80
Cash at Beginning of Period 13,531.00 10,900.00 9,311.00 4,368.30 5,336.10
Cash at End of Period 13,451.00 13,531.00 10,900.00 9,311.40 4,368.30
Diluted Net EPS 2.16 2.02 0.28 5.65 3.64

Zacks Research is Reported On:

Zacks Investment Research

is an A+ Rated BBB

Accredited Business.